These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 17420199)

  • 1. Azithromycin for the secondary prevention of coronary artery disease: a meta-analysis.
    Baker WL; Couch KA
    Am J Health Syst Pharm; 2007 Apr; 64(8):830-6. PubMed ID: 17420199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of antibiotic therapy on outcomes of patients with coronary artery disease: a meta-analysis of randomized controlled trials.
    Andraws R; Berger JS; Brown DL
    JAMA; 2005 Jun; 293(21):2641-7. PubMed ID: 15928286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Azithromycin for the secondary prevention of coronary heart disease events: the WIZARD study: a randomized controlled trial.
    O'Connor CM; Dunne MW; Pfeffer MA; Muhlestein JB; Yao L; Gupta S; Benner RJ; Fisher MR; Cook TD;
    JAMA; 2003 Sep; 290(11):1459-66. PubMed ID: 13129985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized secondary prevention trial of azithromycin in patients with coronary artery disease: primary clinical results of the ACADEMIC study.
    Muhlestein JB; Anderson JL; Carlquist JF; Salunkhe K; Horne BD; Pearson RR; Bunch TJ; Allen A; Trehan S; Nielson C
    Circulation; 2000 Oct; 102(15):1755-60. PubMed ID: 11023928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrolide therapy for Chlamydia pneumoniae in the secondary prevention of coronary artery disease: a meta-analysis of randomized controlled trials.
    Etminan M; Carleton B; Delaney JA; Padwal R
    Pharmacotherapy; 2004 Mar; 24(3):338-43. PubMed ID: 15040646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of short-term treatment with azithromycin on recurrent ischaemic events in patients with acute coronary syndrome in the Azithromycin in Acute Coronary Syndrome (AZACS) trial: a randomised controlled trial.
    Cercek B; Shah PK; Noc M; Zahger D; Zeymer U; Matetzky S; Maurer G; Mahrer P;
    Lancet; 2003 Mar; 361(9360):809-13. PubMed ID: 12642046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Azithromycin for the secondary prevention of coronary events.
    Grayston JT; Kronmal RA; Jackson LA; Parisi AF; Muhlestein JB; Cohen JD; Rogers WJ; Crouse JR; Borrowdale SL; Schron E; Knirsch C;
    N Engl J Med; 2005 Apr; 352(16):1637-45. PubMed ID: 15843666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotics for preventing lower respiratory tract infections in high-risk children aged 12 years and under.
    Onakpoya IJ; Hayward G; Heneghan CJ
    Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD011530. PubMed ID: 26408070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic treatment of atherosclerosis.
    Muhlestein JB
    Curr Opin Lipidol; 2003 Dec; 14(6):605-14. PubMed ID: 14624138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationale and design of a secondary prevention trial of antibiotic use in patients after myocardial infarction: the WIZARD (weekly intervention with zithromax [azithromycin] for atherosclerosis and its related disorders) trial.
    Dunne MW
    J Infect Dis; 2000 Jun; 181 Suppl 3():S572-8. PubMed ID: 10839762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary prevention of atherosclerosis through chlamydia pneumoniae eradication (SPACE Trial): a randomised clinical trial in patients with peripheral arterial disease.
    Vainas T; Stassen FR; Schurink GW; Tordoir JH; Welten RJ; van den Akker LH; Kurvers HA; Bruggeman CA; Kitslaar PJ
    Eur J Vasc Endovasc Surg; 2005 Apr; 29(4):403-11. PubMed ID: 15749042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Description and status of the azithromycin and coronary events study (ACES).
    Jackson LA
    J Infect Dis; 2000 Jun; 181 Suppl 3():S579-81. PubMed ID: 10839763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of a brief course of azithromycin on soluble cell adhesion molecules and markers of inflammation in survivors of an acute coronary syndrome: A double-blind, randomized, placebo-controlled study.
    Hillis GS; Pearson CV; Harding SA; Sutherland S; Ludlam CA; Marioni JC; Prescott RJ; Fox KA; Flapan AD
    Am Heart J; 2004 Jul; 148(1):72-9. PubMed ID: 15215794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD).
    Herath SC; Poole P
    Cochrane Database Syst Rev; 2013 Nov; (11):CD009764. PubMed ID: 24288145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotics for the secondary prevention of ischemic heart disease: a meta-analysis of randomized controlled trials.
    Wells BJ; Mainous AG; Dickerson LM
    Arch Intern Med; 2004 Oct; 164(19):2156-61. PubMed ID: 15505130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular events and safety outcomes associated with azithromycin therapy: a meta-analysis of randomized controlled trials.
    Almalki ZS; Guo JJ
    Am Health Drug Benefits; 2014 Sep; 7(6):318-28. PubMed ID: 25558301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection: The Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infection with Chlamydia (ACADEMIC) study.
    Anderson JL; Muhlestein JB; Carlquist J; Allen A; Trehan S; Nielson C; Hall S; Brady J; Egger M; Horne B; Lim T
    Circulation; 1999 Mar; 99(12):1540-7. PubMed ID: 10096928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of azithromycin on endothelial function of patients with coronary artery disease and evidence of Chlamydia pneumoniae infection.
    Hammerschlag MR
    Circulation; 2002 Oct; 106(15):e65-6; author reply e65-6. PubMed ID: 12370232
    [No Abstract]   [Full Text] [Related]  

  • 19. The failure of antibiotics to prevent heart attacks.
    Taylor-Robinson D; Boman J
    BMJ; 2005 Aug; 331(7513):361-2. PubMed ID: 16096289
    [No Abstract]   [Full Text] [Related]  

  • 20. Azithromycin for acute lower respiratory tract infections.
    Panpanich R; Lerttrakarnnon P; Laopaiboon M
    Cochrane Database Syst Rev; 2004 Oct; (4):CD001954. PubMed ID: 15497172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.